Durability of SARS-CoV-2 Antibodies from Natural Infection in Children and Adolescents

  1. Sarah E. Messiah
  2. Frances Brito
  3. Harold W. Kohl
  4. Stacia DeSantis
  5. Melissa Valerio-Shewmaker
  6. Jessica Ross
  7. Michael D. Swartz
  8. Ashraf Yaseen
  9. Steven H. Kelder
  10. Shiming Zhang
  11. Onyinye S Omega-Njemnobi
  12. Michael O. Gonzalez
  13. Leqing Wu
  14. Eric Boerwinkle
  15. David Lakey
  16. Jennifer A. Shuford
  17. Stephen J. Pont
1 evaluations Published on
Read the full article Related papers
This article on Sciety

Abstract

The authors have withdrawn this manuscript for the following reasons:

  • Our latest analysis (mid-February, 2022) that includes the addition of 59 children with 3 completed timepoints shows a decrease in N antibodies at T2, versus this preprint that showed an increase in N antibodies from T1 to T2.

  • This preprint did not include those infected with the Omicron variant, which has had a substantial impact on the increase in pediatric infections and has important implications for antibody durability moving forward as such.

Therefore, the authors do not wish this work to be cited as reference for the project. If you have any questions, please contact the corresponding author.

Related articles

Related articles are currently not available for this article.